Clopidogrel Use in CYP2C19 Loss-of-Function Carriers With High Bleeding Risk After Percutaneous Coronary Intervention. Sawayama Y, Tomita Y, Kohyama S, Higo Y, et al. Circ J 2023;87:755-763.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sawayama Y, Tomita Y, Kohyama S, Higo Y, et al. Clopidogrel Use in CYP2C19 Loss-of-Function Carriers With High Bleeding Risk After Percutaneous Coronary Intervention. Circ J 2023;87:755-763.
PMID: 36792180